找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cutaneous Disorders of Pregnancy; Kelly H. Tyler Book 2020 Springer Nature Switzerland AG 2020 cutaneous disorders.pregnancy.obstetrics.pr

[復(fù)制鏈接]
31#
發(fā)表于 2025-3-27 00:59:54 | 只看該作者
32#
發(fā)表于 2025-3-27 02:49:03 | 只看該作者
33#
發(fā)表于 2025-3-27 08:19:39 | 只看該作者
A History of Chinese Science and Technologyymptoms, suppress infection, prevent scarring, and improve self-perception while avoiding potential side effects for mother and child. Unfortunately, few of these treatments have been adequately studied for efficacy and safety in the pregnant population.
34#
發(fā)表于 2025-3-27 12:13:49 | 只看該作者
35#
發(fā)表于 2025-3-27 16:06:55 | 只看該作者
ous conditions will be covered in detail.?.Cutaneous Skin Disorders of Pregnancy.?is developed by dermatologists and OB/GYNs and will serve as an invaluable resource for General Dermatologists, Obstetricians/Gy978-3-030-49287-8978-3-030-49285-4
36#
發(fā)表于 2025-3-27 20:09:00 | 只看該作者
37#
發(fā)表于 2025-3-27 22:51:42 | 只看該作者
Autoimmune Connective Tissue Diseasese, as these therapies are shown to be advantageous with regard to fetal outcomes. Intravenous immunoglobulin (IVIG) can be considered as a third or fourth-line treatment. Medications to avoid include methotrexate, mycophenolate mofetil, and acitretin.
38#
發(fā)表于 2025-3-28 04:15:44 | 只看該作者
https://doi.org/10.1007/978-1-349-00554-3e, as these therapies are shown to be advantageous with regard to fetal outcomes. Intravenous immunoglobulin (IVIG) can be considered as a third or fourth-line treatment. Medications to avoid include methotrexate, mycophenolate mofetil, and acitretin.
39#
發(fā)表于 2025-3-28 08:37:29 | 只看該作者
2662-6675 ncluding China, Hungary, the United Kingdom, Poland, and the United States and will be relevant to those interested in emerging and transition economies, the political economy, economic policy, and international relations..978-3-030-48297-8978-3-030-48295-4Series ISSN 2662-6675 Series E-ISSN 2662-6683
40#
發(fā)表于 2025-3-28 13:37:26 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 23:18
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
呈贡县| 汕头市| 甘谷县| 罗定市| 云南省| 建湖县| 新乡市| 栖霞市| 宁城县| 翁源县| 米脂县| 南安市| 广饶县| 清河县| 揭阳市| 达尔| 上饶市| 固原市| 靖安县| 岫岩| 武邑县| 梅河口市| 宝丰县| 德格县| 行唐县| 青州市| 崇阳县| 博罗县| 渭源县| 二连浩特市| 长岛县| 泰安市| 安乡县| 遂溪县| 麟游县| 古浪县| 东乌| 定西市| 石渠县| 邛崃市| 宁远县|